- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A GP challenged a Prescriber journal ad for Micardis and Micardis Plus. The Panel ruled the headline implied unproven long-term cardiovascular benefits,…
A Champix journal ad claimed significantly greater quit success vs an NRT patch. The PMCPA Panel ruled the claim misleading because the…
Allergan materials and representative messaging suggested Xeomin was ~70% as potent as Botox based on animal assay data. PMCPA found the comparison…
A nurse alleged she was suspended for refusing to share confidential unit/customer data from an infusion service facilitation programme. The Panel found…
A member of the public saw Triumeq promotional material on a third-party employee’s iPad on a train. Panel ruled no promotion to…
A prescribing adviser challenged Targinact materials implying simple switches from co-codamol/tramadol. PMCPA ruled the unqualified “instead of” conversion messaging misleading and a…
Two Mezavant XL leavepieces implied the drug induced and maintained remission in 68% of patients. PMCPA ruled the presentation misleading because the…
MSD’s Cozaar ad claimed losartan was “as effective as other leading AIIAs” and quoted a Cochrane review. PMCPA found the presentation/quoting misleading…
Alcon challenged Allergan’s NHS retrospective cash rebate scheme for glaucoma drops as an inducement. The Panel initially found breaches, but the Appeal…
Anonymous GP alleged Lilly reps said long-acting exenatide would launch “within months”. Panel found complaint not proven on balance of probabilities; no…
A NiQuitin 21mg Clear Patch mailing used pharmacokinetic comparisons and “no other patch…” claims. Panel found misleading implied superiority/causal links and breaches…
Anonymous complaint upheld in part: Seretide materials referenced the MHRA (breach Clause 9.5 x2) and Avamys was described as “new” for over…
Norgine funded and coordinated a PR-led campaign that resulted in a Times letter opposing automatic generic substitution, but the published letter did…
Otsuka Europe was found in breach after a withdrawn advert appeared in an EPA programme and extensive congress materials (62/64 job bags)…
A UK employee ‘liked’ a global LinkedIn post calling Qutenza “highly effective”. The Panel said the ‘like’ disseminated promotion to the public…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.